(ALAB) Astera Labs - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US04626A1034

Stock:

Total Rating 54

Risk 40

Buy Signal -1.09

Semiconductors -3.7
Semiconductors -4.5

Market Cap: 20,227m
Avg Trading Vol: 664M USD

ATR: 9.64%
Peers RS (IBD): 16.39

Risk 5d forecast
Volatility	92.6%
Relative Tail Risk	-11.9%

Reward TTM
Sharpe Ratio	0.90
Alpha	6.99

Character TTM
Beta	2.538
Beta Downside	1.428

Drawdowns 3y
Max DD	63.69%
CAGR/Max DD	0.63

EPS (Earnings per Share)

EPS CAGR: 119.85%
EPS Trend: 89.2%

Last SUE: 1.27
Qual. Beats: 3

Revenue

Rev. CAGR: 116.20%
Rev. Trend: 92.1%

Last SUE: 3.44
Qual. Beats: 4

Risks

Fundamental:

P/E ratio: 97.4016

Technicals: volatile

Description: ALAB Astera Labs

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. It offers an intelligent connectivity platform, comprised of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS. The company provides COSMOS software suite, a connectivity system management and optimization software that enables management and optimization of resources for large fleets at cloud-scale via link, fleet, and RAS management capabilities. In addition, it offers PCIe/CXL smart DSP retimers and cable modules; ethernet smart cable modules for cloud and AI infrastructure; CXL memory connectivity controllers; and smart fabric switches. The company serves hyperscalers and system original equipment manufacturers. Astera Labs, Inc. was incorporated in 2017 and is based in San Jose, California.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income: 219.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.18 > 0.02 and ΔFCF/TA 8.68 > 1.0
NWC/Revenue: 144.2% < 20% (prev 233.8%; Δ -89.62% < -1%)
CFO/TA 0.21 > 3% & CFO 319.3m > Net Income 219.1m
Net Debt (-132.5m) to EBITDA (203.7m): -0.65 < 3
Current Ratio: 10.24 > 1.5 & < 3
Outstanding Shares: last quarter (181.2m) vs 12m ago 2.04% < -2%
Gross Margin: 75.69% > 18% (prev 0.76%; Δ 7492 % > 0.5%)
Asset Turnover: 65.93% > 50% (prev 37.58%; Δ 28.34% > 0%)
Interest Coverage Ratio: -9.23 > 6 (EBITDA TTM 203.7m / Interest Expense TTM -21.3m)

Altman Z'' 6.40

A: 0.80 (Total Current Assets 1.36b - Total Current Liabilities 133.0m) / Total Assets 1.53b
B: 0.01 (Retained Earnings 10.3m / Total Assets 1.53b)
C: 0.15 (EBIT TTM 196.8m / Avg Total Assets 1.29b)
D: 0.09 (Book Value of Equity 14.7m / Total Liabilities 168.2m)
Altman-Z'' Score: 6.40 = AAA

Beneish M 1.00

DSRI: 1.00 (Receivables 83.2m/38.8m, Revenue 852.5m/396.3m)
GMI: 1.01 (GM 75.69% / 76.38%)
AQI: 9.11 (AQ_t 0.05 / AQ_t-1 0.01)
SGI: 2.15 (Revenue 852.5m / 396.3m)
TATA: -0.07 (NI 219.1m - CFO 319.3m) / TA 1.53b)
Beneish M-Score: 2.54 (Cap -4..+1) = D

What is the price of ALAB shares?

As of March 02, 2026, the stock is trading at USD 118.83 with a total of 5,119,579 shares traded.
Over the past week, the price has changed by -7.34%, over one month by -22.05%, over three months by -28.06% and over the past year by +75.58%.

Is ALAB a buy, sell or hold?

Astera Labs has received a consensus analysts rating of 4.47. Therefore, it is recommended to buy ALAB.

StrongBuy: 9
Buy: 7
Hold: 1
Sell: 0
StrongSell: 0

What are the forecasts/targets for the ALAB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	204.5	72.1%
Analysts Target Price	204.5	72.1%

ALAB Fundamental Data Overview March 01, 2026

P/E Trailing = 97.4016
P/E Forward = 52.6316
P/S = 23.7255
P/B = 15.5618
Revenue TTM = 852.5m USD
EBIT TTM = 196.8m USD
EBITDA TTM = 203.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 4.44m USD (from shortTermDebt, two quarters ago)
Debt = 35.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -132.5m USD (from netDebt column, last quarter)
Enterprise Value = 19.07b USD (20.23b + Debt 35.1m - CCE 1.19b)
Interest Coverage Ratio = -9.23 (Ebit TTM 196.8m / Interest Expense TTM -21.3m)
EV/FCF = 67.69x (Enterprise Value 19.07b / FCF TTM 281.8m)
FCF Yield = 1.48% (FCF TTM 281.8m / Enterprise Value 19.07b)
FCF Margin = 33.05% (FCF TTM 281.8m / Revenue TTM 852.5m)
Net Margin = 25.70% (Net Income TTM 219.1m / Revenue TTM 852.5m)
Gross Margin = 75.69% ((Revenue TTM 852.5m - Cost of Revenue TTM 207.3m) / Revenue TTM)
Gross Margin QoQ = 75.57% (prev 76.25%)
Tobins Q-Ratio = 12.45 (Enterprise Value 19.07b / Total Assets 1.53b)
Interest Expense / Debt = -60.65% (Interest Expense -21.3m / Debt 35.1m)
Taxrate = 43.00% (33.9m / 78.9m)
NOPAT = 112.2m (EBIT 196.8m * (1 - 43.00%))
Current Ratio = 10.24 (Total Current Assets 1.36b / Total Current Liabilities 133.0m)
Debt / Equity = 0.03 (Debt 35.1m / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = -0.65 (Net Debt -132.5m / EBITDA 203.7m)
Debt / FCF = -0.47 (Net Debt -132.5m / FCF TTM 281.8m)
Total Stockholder Equity = 1.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.95% (Net Income 219.1m / Total Assets 1.53b)
RoE = 18.21% (Net Income TTM 219.1m / Total Stockholder Equity 1.20b)
RoCE = 14.07% (EBIT 196.8m / Capital Employed (Total Assets 1.53b - Current Liab 133.0m))
RoIC = 9.76% (NOPAT 112.2m / Invested Capital 1.15b)
WACC = 15.24% (E(20.23b)/V(20.26b) * Re(15.27%) + (debt cost/tax rate unavailable))
Discount Rate = 15.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 96.29%
[DCF] Terminal Value 61.21% ; FCFF base≈210.0m ; Y1≈259.1m ; Y5≈441.2m
[DCF] Fair Price = 18.15 (EV 2.96b - Net Debt -132.5m = Equity 3.09b / Shares 170.2m; r=15.24% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 89.15 | EPS CAGR: 119.8% | SUE: 1.27 | # QB: 3
Revenue Correlation: 92.05 | Revenue CAGR: 116.2% | SUE: 3.44 | # QB: 4
EPS next Quarter (2026-06-30): EPS=0.55 | Chg7d=+0.012 | Chg30d=+0.011 | Revisions Net=+5 | Analysts=19
EPS current Year (2026-12-31): EPS=2.45 | Chg7d=+0.087 | Chg30d=+0.085 | Revisions Net=+9 | Growth EPS=+33.4% | Growth Revenue=+57.8%
EPS next Year (2027-12-31): EPS=3.49 | Chg7d=+0.237 | Chg30d=+0.238 | Revisions Net=+9 | Growth EPS=+42.2% | Growth Revenue=+37.7%
[Analyst] Revisions Ratio: +0.29 (11 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 14.2% (Discount Rate 15.3% - Earnings Yield 1.0%)
[Growth] Growth Spread = +46.5% (Analyst 60.8% - Implied 14.2%)

Additional Sources for ALAB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle